Delayed booster vaccination with rVSV∆G-ZEBOV-GP at 18 months promotes durable EBOV-neutralizing antibodies Longitudinal antibody repertoire ...
CLINICAL BRIEFINGS 18 February 2026 In an experimental trial, a personalized mRNA vaccine was tested ...
Cell lines For macrophages, the RAW 264.7 cell line was purchased from Shanghai Yu Chun ...
CXCR4 marks CD4+ memory T cells associated with AML remission To identify features linked to ...